Business
Only Opella’s own Enterogermina brand was found by a company-funded study to be contamination-free, to contain the claimed content, and show resistance to all tested antibiotics.
Vision Healthcare adds an established supplements portfolio, alongside a robust omni-channel set-up across the Nordics, with the acquisition of BioSalma.
Research from UK retailer Holland & Barrett, the University of East Anglia and the University of Southampton points to need for Omega-3 supplementation for many consumers.
Urban Retreat didn’t cooperate with Direct Selling Self-Regulatory Council’s review or “indicate any intent to comply with” recommendations to discontinue claims for its Balance Capsules. LoveBiome responded sufficiently to merit a DSSRC recommendation to pull three health claims.
Innovation & IP
“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.
France's Valbiotis has joined forces with China-based Aika to roll out its plant-based dietary supplements in selected Asian markets.
The European Commission has added magnesium L-threonate to the list of vitamin and mineral substances which may be used in the manufacture of dietary supplements.
MultiBurn supplement launch “is creating kind of a new focus I would say around weight loss, where quite honestly, we’ve been probably more of a healthy active lifestyle,” says CEO Stephan Gratziani. Pro2Col app for personalized wellness launching before January.
Policy & Regulation
Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.
Only Opella’s own Enterogermina brand was found by a company-funded study to be contamination-free, to contain the claimed content, and show resistance to all tested antibiotics.
Third-Party Audit Results ‘Definitely The Direction’ For FDA Supplement Facility Inspection Planning
“There's a lot of third-party audit information out there. Could we take that and apply it into our inspectional planning process?” says Office of Dietary Supplement Programs Director Cara Welch.
“We have rarely, if ever, enforced this requirement” FDA says announcing enforcement discretion regarding requirement for disclaimer about supplement structure/function and other label claims to be printed on every panel of a product’s package.










